跳至主要内容
临床试验/ISRCTN11225767
ISRCTN11225767已完成3 期

Tranexamic acid for the treatment of gastrointestinal haemorrhage: an international randomised, double blind placebo controlled trial

ondon School of Hygiene and Tropical Medicine (UK)0 个研究点目标入组 12,009 人开始时间: 2012年7月3日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
12,009

研究概览

简要总结

2014 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/25409738 2019 statistical analysis plan in: https://www.ncbi.nlm.nih.gov/pubmed/31362765 (added 01/08/2019) 2020 results in https://doi.org/10.1016/S0140-6736(20)30848-5 (added 23/07/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. All adult patients with acute significant upper or lower gastrointestinal bleeding
  • 2. Where the responsible clinician is substantially uncertain as to the appropriateness of antifibrinolytic agents in the patient

排除标准

  • The fundamental eligibility criterion is the responsible clinician's 'uncertainty' as to whether or not to use an antifibrinolytic agent in a particular patient with upper or lower gastrointestinal bleeding.

研究者

发起方
ondon School of Hygiene and Tropical Medicine (UK)

相似试验